Money

Natco Pharma is facing one of its worst public image crises. A variant of the well-known cancer drug paclitaxel that it markets has been dubbed "sub-standard" by none other than the Drug Controller General of India (DCGI).

Popular » Viewed Emailed Money » Zee Turner to take 33 channels off Hathway Cognizant sees offshoring budgets up TechMahindra accounting continues to fox Boeing's new 747 takes flight near Seattle Google's Gmail tweak challenges Facebook, Twitter Other sections » Sena targets Arindham Chaudhari over 'separate Mumbai' remark 200 Shiv Sena activists held for anti-SRK stir SRK protests: Maha CM threatens to withdraw Uddhav's security Pak likely to take tough line on talks India's spy in the sky by 2014 Money » TechMahindra accounting continues to fox India still not lucrative for innovator drugs Tyre shortage hurting CV production For a long-term play, opt for Nabard bonds Barclays CEO: Reform should allow smoother failures Other sections » Now, iPhone application that can cure acne Official's visit has nothing to do with BT Brinjal: US Embassy Auto fare hike makes Bus Rapid Transit System richer in Gujarat Solar energy can be used to combat climate change: Experts Keith Richards, Ronnie Wood together cope with life without the bottle Gallery » Shopping therapy It was a celebrity deluge at the seventh edition of Mana Shetty and Sharmilla Khanna's all-day shopping fest Araaish at Worli. UK throws gauntlet, students pick it up The UK has laid down a new law for foreign students wishing to study on the island, but that has not stopped a large number of young Bangaloreans from heading there. Newsletter » Get daily news in your inbox and read it at your convenience. About DNA | Contact Us | Advertise with Us | Subscription | Reprint Rights ©2010 Diligent Media Corporation Ltd. D 910